Tenofovir vs. entecavir in reducing hepatocellular carcinoma risk in patients with chronic HBV infection?-Still an unsolved question

Hepatobiliary Surg Nutr. 2021 Jan;10(1):119-122. doi: 10.21037/hbsn-2020-3.

Authors

Hyun-Seok Kim¹, Hashem B El-Serag^{1

2}

Affiliations

¹ Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX, USA.
² U.S. Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.

No abstract available

Publication types

Editorial
Comment

Grants and funding